Literature DB >> 10898410

Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening.

R F Redberg1, N Rifai, L Gee, P M Ridker.   

Abstract

OBJECTIVES: We sought to test the hypothesis that C-reactive protein, a marker of inflammation, would correlate positively with coronary calcium, a marker of atherosclerosis, in postmenopausal women.
BACKGROUND: High sensitivity testing for C-reactive protein (hsCRP) has recently been shown in large population studies to predict cardiac events in asymptomatic postmenopausal women. Coronary calcification determined by electron beam computerized tomography (EBCT) has also been suggested to be predictive of cardiac events in women.
METHODS: We performed hsCRP testing and determined calcium scores by EBCT in 172 asymptomatic postmenopausal women (mean age: 64.5 +/- 7.9 years) at risk for cardiac disease. Risk factors were determined by history, physical, electrocardiogram, exercise testing, and lipoprotein profiles.
RESULTS: Calcium scores ranged from 0 to 2,618. For analysis, calcium scores were divided into three groups; none (0 to 10), minimal (>10 to 50), and significant (>50). Overall, there was no significant positive relationship between hsCRP level and calcium score. Specifically, the hsCRP levels (mg/dl) were 0.24 +/- 0.43, 0.33 +/- 0.47 and 0.17 +/- 0.32 (medians 0.11, 0.15, and 0.06) for women with none, minimal, and significant coronary calcification, respectively. In subgroup analysis, a similar lack of positive association was observed after stratification by smoking status and by hormone replacement therapy use, two factors known to increase hsCRP.
CONCLUSIONS: In contrast to our a priori hypothesis, we found no evidence of a positive association between hsCRP and calcium score by EBCT. These data thus raise the possibility that hsCRP and EBCT calcium score reflect different pathologic processes, an issue with implications for coronary artery disease screening.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898410     DOI: 10.1016/s0735-1097(00)00680-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

Review 1.  Role of noninvasive imaging in asymptomatic high-risk patients.

Authors:  Leslee J Shaw; Allen Taylor; Paolo Raggi; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

2.  Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes.

Authors:  Atif N Qasim; Venkata Budharaju; Nehal N Mehta; Caitlin St Clair; Samira Farouk; Seth Braunstein; Mark Schutta; Nayyar Iqbal; Daniel J Rader; Muredach P Reilly
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

3.  Comparison of characteristics of future myocardial infarctions in women with baseline high versus baseline low levels of high-sensitivity C-reactive protein.

Authors:  Sandeep Bansal; Paul M Ridker
Journal:  Am J Cardiol       Date:  2007-04-12       Impact factor: 2.778

Review 4.  Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium.

Authors:  Waqas T Qureshi; Jamal S Rana; Joseph Yeboah; Usama Bin Nasir; Mouaz H Al-Mallah
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

Review 5.  The endothelium: dysfunction and beyond.

Authors:  J Herrmann; A Lerman
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

6.  Differential associations between blood biomarkers of inflammation, oxidation, and lipid metabolism with varying forms of coronary atherosclerotic plaque as quantified by coronary CT angiography.

Authors:  Fabian Bamberg; Quynh A Truong; Wolfgang Koenig; Christopher L Schlett; Khurram Nasir; Javed Butler; Emily Kurtz; Konstantin Nikolaou; Udo Hoffmann; James L Januzzi
Journal:  Int J Cardiovasc Imaging       Date:  2011-01-09       Impact factor: 2.357

7.  C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study.

Authors:  Mary S Beattie; Michael G Shlipak; Haiying Liu; Warren S Browner; Nelson B Schiller; Mary A Whooley
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

Review 8.  Women and ischemic heart disease: evolving knowledge.

Authors:  Leslee J Shaw; Raffaelle Bugiardini; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

Review 9.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

10.  Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients.

Authors:  Eugenia Raichlin; Joseph P McConnell; Jang-Ho Bae; Walter K Kremers; Amir Lerman; Robert P Frantz
Journal:  Transplantation       Date:  2008-04-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.